p53 Mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas

This publication has 36 references indexed in Scilit:

• It was a very good year for DNA repair
  Cell, 1994
• Clinical Implications of the p53 Tumor-Suppressor Gene
  New England Journal of Medicine, 1993
• Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53
  Nature, 1993
• Correlation between HPV Positivity and State of the p53 Gene in Cervical Carcinoma Cell Lines
  Gynecologic Oncology, 1993
• Frequent Occurrence of p53 Gene Mutations in Uterine Cancers at Advanced Clinical Stage and with Aggressive Histological Phenotypes
  Japanese Journal of Cancer Research, 1992
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
  Cell, 1992
• p53 Mutations in Human Cancers
  Science, 1991
• Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
  Science, 1990
• Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.
  Proceedings of the National Academy of Sciences, 1989
• Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia
  Science, 1985